“Made in Shenzhen” vaccine launches booster dose administration.

Release date:

2022-02-24

Author:

Source:


Abstract

Shenzhen Special Zone Daily reports: “I received my first two doses of the ‘Made in Shenzhen’ COVID‑19 vaccine, and it’s been exactly six months. As soon as I saw that I could book my third dose, I came right over to get it.” On February 22, the first batch of booster shots—third doses—of the inactivated COVID‑19 vaccine developed and manufactured by Shenzhen Kangtai Biological Products Co., Ltd. (referred to as “Kangtai Bio”) officially began being administered. At a vaccination site in Guangming District, Ms. Chen told a reporter with excitement. Currently, all eligible residents can make appointments for the Kangtai Bio inactivated COVID‑19 vaccine booster through the designated vaccination‑booking platform. In June last year, Kangtai Bio’s inactivated COVID‑19 vaccine was launched in Shenzhen; as of…

Shenzhen Special Economic Zone Daily reports: “I received my first two doses of the COVID‑19 vaccine produced in Shenzhen, and it’s been exactly six months. As soon as I saw that I could book my third dose, I came right over to get it.” On February 22, the first batch of booster shots—third doses—of the inactivated COVID‑19 vaccine developed and manufactured by Shenzhen Kangtai Biological Products Co., Ltd. (referred to as “Kangtai Bio”) officially began being administered. At a vaccination site in Guangming District, Ms. Chen told a reporter with excitement. At present, all eligible residents can make appointments for the Kangtai Bio inactivated COVID‑19 vaccine booster shot through the designated vaccination‑appointment platform.

In June last year, Kangtai Biological’s inactivated COVID‑19 vaccine was rolled out for vaccination in Shenzhen and has since been supplied on a large scale to multiple provinces, including Guangdong. On the 19th of this month, the State Council Joint Prevention and Control Mechanism approved Kangtai Biological’s inactivated COVID‑19 vaccine for use as a homologous booster dose, meaning that individuals aged 18 and above who completed the full vaccination course with Kangtai’s inactivated vaccine at least six months ago are eligible for a single booster dose—administered with the same vaccine. Mr. Wang, who received his shot on site, told reporters that he chose the “Shenzhen‑made” COVID‑19 vaccine out of confidence in the quality of products from a local company: “As soon as I got the notice, I came straight to get my third dose—both to help fight the pandemic and to add an extra layer of protection for my own health.”

Li Dong, Director of R&D at Kintgen Biotech, stated that, according to a paper published in the Chinese Medical Journal this January, seven days after receiving a booster dose of Kintgen’s inactivated COVID‑19 vaccine, neutralizing antibody titers against live virus increased rapidly, rising more than 20-fold compared with pre‑booster levels. By day 28, antibody titers remained at a high level, having increased by over 30-fold relative to baseline.

Recommended Reading


Batch Release Status of the Company’s Products in 2026


The company's product 2026 annual batch issuance situation is as follows:

2026-07-23

Good News | Another Star Award! Minhai Biotechnology has once again been recognized as a “Five-Star Green Credit Enterprise” in Daxing District.


Recently, the Daxing District Bureau of Ecology and Environment completed the fifth round of corporate green credit rating for 2025 and officially released the “2025 Daxing District Green Credit Enterprise Directory.” Thanks to its robust environmental management system, consistent compliance performance, and outstanding achievements in energy conservation and carbon reduction, Minhai Biotechnology has once again been awarded the region’s highest “Five-Star Green Credit Enterprise” rating. The Daxing District’s corporate green credit assessment covers five major categories—environmental compliance, pollution control and emission reduction, low‑carbon circular economy, scientific management, and social contribution—comprising a total of 30 sub‑indicators. With stringent standards and comprehensive evaluation, the program employs dynamic review and a veto‑based mechanism, with the Five‑Star rating representing the highest level of ecological credit in the district.

2026-07-15

Good News | The Party Branch of Minhai Biotechnology has been awarded the “Two Excellences and One Pioneer” honor in Beijing’s emerging sectors, as well as a park‑level commendation.


Recently, Beijing held a grand commendation conference for the “Two Excellences and One Pioneer” initiative in emerging sectors. The “Two New” Working Committee of the CPC Beijing Municipal Committee recognized outstanding Communist Party members, exemplary Party affairs workers, and advanced primary-level Party organizations across the city’s emerging fields. The Party branch of Beijing Minhai Biotechnology Co., Ltd. was honored as an advanced primary-level Party organization in Beijing’s emerging sectors. Wu Chengyu, the branch secretary, attended the ceremony in person to receive the award. At the event, the Party flag flew proudly amid a solemn atmosphere, and the awardees, adorned with honor ribbons and holding certificates and medals, jointly witnessed this prestigious municipal recognition. This designation as an advanced primary-level Party organization at the municipal level represents the “Two New” Working Committee of the Municipal Party Committee’s high appraisal of the Minhai Biotechnology Party branch.

2026-07-09